BCL-1 rearrangement in acute lymphocytic leukemia and its clinical significance
β Scribed by Xinyue, Liu ;Zehai, Tang
- Publisher
- Springer-Verlag
- Year
- 2001
- Tongue
- English
- Weight
- 442 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0257-716X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Soluble CD83 (sCD83), a potent immunosuppressive agent, circulates at elevated levels in some chronic lymphocytic leukemia (CLL) patients. We report that CLL patients with elevated plasma sCD83 levels had significantly shorter (P=0.038) treatment free survival. Culture of CLL cells with solid phase
This prospective study was designed to explore the prevalence and the clinical and prognostic significance of anticardiolipin (ACL) antibodies in patients with acute myeloid leukemia (AML). The study includes 37 consecutive AML patients >15 years old without previous history of thromboembolism, recu
## Abstract The __TEL/AML1__ rearrangement has been implicated as an independent good prognostic factor in pediatric acute lymphoblastic leukemia (ALL). We examined __TEL/AML1__ using nested reverseβtranscription polymerase chain reaction (RTβPCR) and correlated __TEL/AML1__ with cytogenetics and i
CD7 antigen, a T-cell lineage associated antigen, is expressed in a minority of patients with acute myeloid leukemia (AML). The biologic and clinical significance of this finding is not clearly established. In this retrospective study of patients with de novo acute myeloid leukemia, we have identifi